In summary, 015s normalises the immunosuppressive tumour microenvironment by simultaneously blocking two key inhibitory pathways, PD-1/PD-L1 and TGF-β, thereby restoring antitumour immunity and demonstrating potent efficacy in murine models. Here, PDCD1 is linked to neoplasm.